Print
|
Sitemap
HOME
ABOUT US
• Company Profile
• Management
• Scientific Advisory Board
TECHNOLOGIES
• GlycoMAb®
• Transient Expression Technology
• Generation of Highly Productive Cell Lines
PIPELINE
LICENSING
CAREERS
PUBLIC RELATIONS
• Agenda
• Press releases & Articles
CONTACT
• Contact Form
• Routenplaner
HOME
Developing a
new
generation of more
potent
therapeutic antibodies
Press releases & Articles
31.12.2005
GlycArt's's success with glycosylated therapeutic proteins
19.07.2005
Roche acquires Swiss based GlycArt Biotechnology to strengthen expertise in therapeutic antibody research
All rights reserved. © GLYCART biotechnology AG 2008
